Apologies if this has been covered, couldn’t find anything in search.
What is BBM’s (or Jordan/Austin’s) take on the significance of glucose variability, peak glucose, etc on chronic illness outcomes or metabolic health in general? I’m not quite interested enough to purchase a CGM and wear it continually, but glucose variability is something Peter Attia has addressed quite a few times in his articles and on his podcast. That said, this snarky but at least apparently reasonable article seems to make some relevant critiques:
I’m currently not terribly inclined to think it makes all that much of a difference, at least in someone working on basics like myself, if one adequately manages lipids and trains reasonably hard and consistently, given the colossal hazard reductions those changes have on ACM.
What is BBM’s (or Jordan/Austin’s) take on the significance of glucose variability, peak glucose, etc on chronic illness outcomes or metabolic health in general?
I’m not trying to be obtuse, but this question is very difficult to answer.
Glucose variability refers to measurements from a continuous glucose monitor (CGM), as A1C cannot capture these deviations. In individuals without metabolic syndrome (per ATP III criteria) or impaired glucose tolerance (e.g. prediabetes), I do not care what a CGM has to say as it does not indicate anything reliably useful for changing what I would do with the individual.
Maintaining appropriate insulin sensitivity and glucose metabolism is important to health. This is in addition to- not in place- of exercise, a health promoting dietary pattern, and managing/reducing risk of other medical conditions (e.g. lipids).